Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Allergy and Immunology
Trial Title   A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy & Safety of Grass (Phleumpratense) Sublingual Tab (SCH 697243) in Subjects Ages 5 to 65 Years w/History of Grass Pollen-Induced Rhinoconjunctivitis
Description of Research   The purpose of this study is to compare how safe and effective the study drug, SCH 697243, is when compared to a placebo (look-alike with no active ingredients, sometimes called a sugar pill) in treating rhinoconjunctivitis (an allergic reaction to grass pollen that causes nose symptoms [itching, runny nose, stuffy nose, sneezing] and eye symptoms [red eyes, itchy eyes, watery eyes]) when taken once daily.
Study Number   HSR-11-1234
Inclusion/Notes   Participants have an allergy to grass pollen.
Principal Investigator   Jeffrey Leflein, MD
Contact Name   Pat Lesak
Phone   (734) 528-0477
A Member of Trinity Health
© 2015 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456